Study #PA16-0935
Characterization of altered T cell immunity in patients with immune toxicities after checkpoint inhibitor therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Immune-related adverse events with checkpoint blockade therapy
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Yuanteng Jeff Li
Department:
Rheumatology
For general questions about clinical trials:
1-877-839-0558
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.